- Home
- UCAR vs ATHA Comparison
UCAR vs ATHA Comparison
Compare UCAR & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- ATHA
- Stock Information
- Founded
- UCAR 2013
- ATHA 2011
- Country
- UCAR China
- ATHA United States
- Employees
- UCAR N/A
- ATHA N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- UCAR Consumer Discretionary
- ATHA Health Care
- Exchange
- UCAR Nasdaq
- ATHA Nasdaq
- Market Cap
- UCAR 24.1M
- ATHA 22.3M
- IPO Year
- UCAR 2023
- ATHA 2020
- Fundamental
- Price
- UCAR $6.60
- ATHA $0.51
- Analyst Decision
- UCAR
- ATHA Buy
- Analyst Count
- UCAR 0
- ATHA 4
- Target Price
- UCAR N/A
- ATHA $11.25
- AVG Volume (30 Days)
- UCAR 24.6K
- ATHA 326.1K
- Earning Date
- UCAR 10-08-2024
- ATHA 02-20-2025
- Dividend Yield
- UCAR N/A
- ATHA N/A
- EPS Growth
- UCAR N/A
- ATHA N/A
- EPS
- UCAR N/A
- ATHA N/A
- Revenue
- UCAR $4,273,899.00
- ATHA N/A
- Revenue This Year
- UCAR N/A
- ATHA N/A
- Revenue Next Year
- UCAR N/A
- ATHA N/A
- P/E Ratio
- UCAR N/A
- ATHA N/A
- Revenue Growth
- UCAR 473.55
- ATHA N/A
- 52 Week Low
- UCAR $4.21
- ATHA $0.41
- 52 Week High
- UCAR $23.00
- ATHA $4.30
- Technical
- Relative Strength Index (RSI)
- UCAR 46.24
- ATHA 35.57
- Support Level
- UCAR $6.35
- ATHA $0.56
- Resistance Level
- UCAR $7.79
- ATHA $0.58
- Average True Range (ATR)
- UCAR 0.49
- ATHA 0.04
- MACD
- UCAR -0.03
- ATHA -0.01
- Stochastic Oscillator
- UCAR 19.05
- ATHA 0.39
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufactory and sales; battery swapping services and sourcing services. The company as a broker engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.